Shoulder Innovations, Inc. (NYSE: SI) announced the initiation of a limited user release of its InSet® Go glenoid implant, a next-generation device for use in anatomic shoulder arthroplasty procedures.

The first surgical case using the InSet® Go was performed by Robert Gillespie, MD, at University Hospitals Cleveland Medical Center in Cleveland, Ohio.

According to the company, the InSet® Go is based on a glenoid technology originally invented more than 20 years ago by Stephen Gunther, MD. The design places the implant within a circumferential rim of bone, which the company says addresses glenoid implant loosening, described as the leading cause of failure in anatomic shoulder replacement.

The next-generation implant is designed to reduce the number of surgical steps involved in the procedure, with the potential for shorter procedure times. It also incorporates additional intellectual property covering the implant's articular surface and augmented configurations for correction of bone loss.

"InSet Go builds on a decade-long track record our surgeons and patients already trust, now paired with a procedure that's meaningfully more efficient for the surgical team and care facility," said Rob Ball, CEO of Shoulder Innovations.

The company said it expects a full commercial introduction of the InSet® Go over the coming quarters, based on a press release statement.